Skip to main content
Clinical Trials/NCT05710796
NCT05710796
Completed
Not Applicable

AN OBSERVATIONAL STUDY ON CARDIOVASCULAR INVOLVEMENT IN COVID RECOVERED PATIENTS

Kakatiya University1 site in 1 country500 target enrollmentSeptember 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gender Discrimination
Sponsor
Kakatiya University
Enrollment
500
Locations
1
Primary Endpoint
ECG, Lipid profile, TMT, and 2D Echo
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Aim of the study is to evaluate the prevalence and bring awareness ofcardiovascular complications in COVID-19 recovered patients. Study is conducted at single site, which is Srinivasa Heart Centre, Warangal, Telangana state in India for the duration of 4 months. The sample size is calculated 500 patients and the study is cohort, observational study. Patient consent has been taken before enrolment.

Detailed Description

The aim of the study is to evaluate the prevalence and bring awareness of cardiovascular complications in COVID-19 recovered patients. Objectives of the study: 1. To study causes and risk factors of cardiac disorders associated with COVID-19 2. To identify different types of cardiac symptoms patients, present with 3. To study the impact of co-morbidities on COVID-19 recovered patients 4. To study treatment patterns and duration of therapy Plan to study: * To select the patient based on inclusion and exclusion criteria * To collect the patient information from case sheets and by patient interaction * To identify different types of cardiac disorders related to COVID-19 or its treatment regimen * To study the management of COVID-19 complication and related cardiovascular disorders Study Sites: Srinivasa Heart Centre, Warangal (T.S) Study Design: Observational cohort study Study Duration: 4 months Subject Eligibility: 1. Inclusion Criteria * Patients who are willing to participate * Patients having previous COVID-19 treatment record * Prescriptions reported during the study period * The prescription which is legible and complete 2. Exclusion Criteria * Patients who are not willing to participate * The patient having no history of COVID-19 and available data Source of the data: 1. Review of patient case sheet, prescription and lab reports 2. Personal interaction with patients and caregivers Sample size: 500 Patients

Registry
clinicaltrials.gov
Start Date
September 1, 2021
End Date
April 29, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Satyam Suman

Department of Pharmacy Practice

Kakatiya University

Eligibility Criteria

Inclusion Criteria

  • Patients who are willing to participate
  • Patients having previous COVID-19 treatment record
  • Prescriptions reported during the study period
  • The prescription which is legible and complete

Exclusion Criteria

  • Patients who are not willing to participate
  • The patient having no history of COVID-19 and available data

Outcomes

Primary Outcomes

ECG, Lipid profile, TMT, and 2D Echo

Time Frame: September 2021 to February 2022

The following tests are performed to every individuals and relevant report are considered

Study Sites (1)

Loading locations...

Similar Trials